share_log

Zymeworks Reports Preliminary Phase 1 Trial Results For Zanidatamab Zovodotin (ZW49) At European Society For Medical Oncology Annual Congress; Co To Host Conference Call, Webcast At 4:30 P.m. EDT Today

Benzinga Real-time News ·  Sep 12, 2022 16:16
Zymeworks Reports Preliminary Phase 1 Trial Results For Zanidatamab Zovodotin (ZW49) At European Society For Medical Oncology Annual Congress; Co To Host Conference Call, Webcast At 4:30 p.m. EDT Today
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment